Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 December 2008, Vol. 112, No. 13, pp. 4784-4785.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, J. S.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

HEMOSTASIS

Comment on Verhaar et al, page 4935

UV-C irradiation gives platelets a sunburn

Joel S. Bennett

UNIVERSITY OF PENNSYLVANIA

In this issue of Blood, Verhaar and colleagues report that, although UV-C irradiation is an attractive method to minimize microbial contamination of platelet concentrates, it directly activates platelet {alpha}IIbβ3 by reducing critical extracellular disulfide bonds, resulting in the aggregation of stored platelets.

With the largely successful advent of viral testing, bacterial contamination has become the major infectious complication of transfusion. This is particularly relevant for platelets that must be stored at 20°C to 24°C to preserve platelet function, unfortunately resulting in a permissive environment for growth of bacterial contaminants. In fact, microbiologic testing of platelet products has revealed contamination rates of between 1 in 2000 and 1 in 40001 as well as a risk of clinical sepsis from apheresis platelets that can be as high as 1 in 15 000 infusions.2 Accordingly, platelet storage has been limited to 5 days to minimize the extent of bacterial growth.

Bacterial contamination of blood products can result from inadequate skin cleansing, from a small core of skin that sometimes enters the phlebotomy needle, and from contaminated blood collection packs.3 Thus, obvious ways to reduce contamination are to improve skin disinfection, to discard the first 15 to 30 mL of collected blood, and to culture or otherwise screen platelet products for the presence of bacteria.3 Another approach is to inactivate the contaminating bacteria.

Photodynamic and photochemical methods using ultraviolet (UV) light have been developed to inactivate bacteria in platelet products by damaging their DNA and RNA. Thus, irradiating platelet concentrates containing psoralen derivatives with UV-A light (wave length 315-400 nm) induces pyrimidine crosslinks in bacterial DNA and RNA, preventing subsequent replication and transcription. In the SPRINT trial, transfused platelets that had been irradiated with UV-A in the presence of the psoralen amotosalen were as hemostatically effective as control platelets. However, the photochemical treatment resulted in lower platelet increments and shorter intervals between transfusions, suggesting that it had caused mild platelet injury.4 Although UV-B irradiation (wave length 280-315 nm) has been used primarily to prevent HLA sensitization and platelet refractoriness, it has been combined with the dye thionine and yellow light in a 2-step procedure to inactivate bacteria in platelet concentrates.5 Enthusiasm for UV-B as a decontaminant, however, must be tempered by the report by van Marwijk Kooy et al, which found that UV-B irradiation causes platelet aggregation via oxygen radical-induced activation of protein kinase C.6

In contrast to UV-A and UV-B, UV-C irradiation (wave length 100-280 nm) reduces bacterial growth in platelet concentrates without the need for photosensitizing additives. However, Terpstra et al observed that when platelets suspended in 10% plasma were irradiated with UV-C light, there was dose-dependent LDH release, P-selectin expression, and phosphotidylserine exposure that was mitigated to some extent by increasing the plasma concentration to 30%.7 In the work reported in this issue of Blood, the same group of investigators has studied the mechanism responsible for the decrease in platelet count that occurs during storage of UV-C–treated platelets. They found that relatively high-dose UV-C irradiation (1500 J/m2) caused immediate, {alpha}IIbβ3-dependent, platelet aggregation, implying that aggregate formation was the cause for the decreased platelet counts. Interestingly, UV-C–induced platelet aggregation was independent of platelet signal transduction. For example, it was unaffected by increasing platelet cAMP with forskolin, but it was associated with a marked increase in free thiol groups on the platelet surface, including free thiols in {alpha}IIbβ3. Incubating platelets with the reducing agent dithiothreitol has been known for decades to induce platelet aggregation, presumably by reducing critical but, as yet, unidentified disulfide bonds in {alpha}IIbβ3.8 Thus, the authors speculate that disulfide bond photolysis induced by UV-C irradiation was responsible for the platelet aggregation they observed.

The bacteriocidal properties of UV-C radiation would make it seem an ideal solution for the infectious complications of platelet transfusion. But the chemistry responsible for its bactericidal properties also has unexpected but unavoidable novel consequences on platelet function. It's not easy to mess with Mother Nature.

Footnotes

Conflict-of-interest disclosure: The author declares no competing financial interests. {blacksquare}

REFERENCES

  1. Bryant BJ, Klein HG. Pathogen inactivation: the definitive safeguard for the blood supply. Arch Pathol Lab Med. 2007;131:719–733.[Medline] [Order article via Infotrieve]

  2. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood. 2008;112:2617–2626.[Abstract/Free Full Text]

  3. Hillyer CD, Josephson CD, Blajchman MA, et al. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology. 2003;575–589.

  4. Murphy S, Snyder E, Cable R, et al. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light. Transfusion. 2006;46:24–33.[CrossRef][Medline] [Order article via Infotrieve]

  5. Mohr H, Redecker-Klein A. Inactivation of pathogens in platelet concentrates by using a two-step procedure. Vox Sang. 2003;84:96–104.[CrossRef][Medline] [Order article via Infotrieve]

  6. van Marwijk Kooy M, Akkerman JW, van Asbeck S, et al. UVB radiation exposes fibrinogen binding sites on platelets by activating protein kinase C via reactive oxygen species. Br J Haematol. 1993;83:253–258.[CrossRef][Medline] [Order article via Infotrieve]

  7. Terpstra FG, van 't Wout AB, Schuitemaker H, et al. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates. Transfusion. 2008;48:304–313.[Medline] [Order article via Infotrieve]

  8. Zucker MB, Masiello NC. Platelet aggregation caused by dithiothreitol. Thromb Haemost. 1984;51:119–124.[Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin {alpha}IIbβ3
Robin Verhaar, David W. C. Dekkers, Iris M. De Cuyper, Mark H. Ginsberg, Dirk de Korte, and Arthur J. Verhoeven
Blood 2008 112: 4935-4939. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, J. S.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020